Aquestive Therapeutics (AQST) Invested Capital (2018 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Invested Capital of $13.7 million for Q1 2026, up 50496.3% year-over-year from N/an in Q1 2025, and up 36.69% quarter-over-quarter from $10.0 million in Q4 2025.
Aquestive Therapeutics (AQST) Invested Capital (2018 - 2026) Analysis & Trends
Aquestive Therapeutics' Invested Capital history runs 9 years deep, the most recent figure standing at $13.7 million for Q1 2026.
- In Q1 2026, Invested Capital rose 50496.3% year-over-year to $13.7 million; the TTM figure through Mar 2026 stood at $33.2 million (up 32408.82% YoY), while the FY2025 annual figure was $10.0 million, up 38338.46% from the prior year.
- Invested Capital for Q1 2026 stood at $13.7 million, up from $10.0 million in the prior quarter.
- The five-year high for Invested Capital was $18.7 million in Q4 2022, with the low at $22000.0 in Q4 2023.
- The 5-year median for Invested Capital is $6.3 million (2025), against an average of $7.2 million.
- The sharpest annual moves came in 2023 and 2026: Invested Capital plunged 99.88% in 2023, then soared 50496.3% in 2026.
- Aquestive Therapeutics' Invested Capital stood at $18.7 million in 2022, then slumped by 99.88% to $22000.0 in 2023, then grew by 18.18% to $26000.0 in 2024, then jumped by 38338.46% to $10.0 million in 2025, then soared by 36.69% to $13.7 million in 2026.
- Business Quant data shows AQST's Invested Capital at $13.7 million in Q1 2026, $10.0 million in Q4 2025, and $6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 630.00 Mn |
| 10 | Aquestive Therapeutics | 553.10 Mn | 553.10 Mn | 9.80 Mn | 32,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 13.66 Mn |
| Dec 31, 2025 | 9.99 Mn |
| Sep 30, 2025 | 6.33 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 4.61 Mn |
| Jun 30, 2023 | 18.36 Mn |
| Mar 31, 2023 | 17.20 Mn |
| Dec 31, 2022 | 18.70 Mn |
| Sep 30, 2022 | 14.23 Mn |
| Jun 30, 2022 | 9.75 Mn |
| Mar 31, 2022 | 6.56 Mn |
| Dec 31, 2021 | 2.03 Mn |
| Sep 30, 2021 | 7.73 Mn |